Keywords
Exploration
Accueil
Racine
Exploration
Accueil
Racine

Serveur d'exploration sur la COVID en France - Exploration (Accueil)

Index « Keywords » - entrée « Hydroxychloroquine (adverse effects) »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Hydroxychloroquine (administration & dosage) < Hydroxychloroquine (adverse effects) < Hydroxychloroquine (blood)  Facettes :

List of bibliographic references indexed by Hydroxychloroquine (adverse effects)

Number of relevant bibliographic references: 14.
Ident.Authors (with country if any)Title
000011 (2020) Matthieu Million [France] ; Jean-Christophe Lagier [France] ; Philippe Gautret [France] ; Philippe Colson [France] ; Pierre-Edouard Fournier [France] ; Sophie Amrane [France] ; Marie Hocquart [France] ; Morgane Mailhe [France] ; Vera Esteves-Vieira [France] ; Barbara Doudier [France] ; Camille Aubry [France] ; Florian Correard [France] ; Audrey Giraud-Gatineau [France] ; Yanis Roussel [France] ; Cyril Berenger [France] ; Nadim Cassir [France] ; Piseth Seng [France] ; Christine Zandotti [France] ; Catherine Dhiver [France] ; Isabelle Ravaux [France] ; Christelle Tomei [France] ; Carole Eldin [France] ; Hervé Tissot-Dupont [France] ; Stéphane Honoré [France] ; Andreas Stein [France] ; Alexis Jacquier [France] ; Jean-Claude Deharo [France] ; Eric Chabrière [France] ; Anthony Levasseur [France] ; Florence Fenollar [France] ; Jean-Marc Rolain [France] ; Yolande Obadia [France] ; Philippe Brouqui [France] ; Michel Drancourt [France] ; Bernard La Scola [France] ; Philippe Parola [France] ; Didier Raoult [France]Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.
000060 (2020) M. Roustit [France] ; R. Guilhaumou [France] ; M. Molimard [France] ; M-D Drici [France] ; S. Laporte [France] ; J-L Montastruc [France]Chloroquine and hydroxychloroquine in the management of COVID-19: Much kerfuffle but little evidence.
000061 (2020) Isabelle Lacroix [France] ; Justine Bénévent [France] ; Christine Damase-Michel [France]Chloroquine and hydroxychloroquine during pregnancy: What do we know?
000065 (2020) Alexandre Gérard [France] ; Serena Romani [France] ; Audrey Fresse [France] ; Delphine Viard [France] ; Nadège Parassol [France] ; Aurélie Granvuillemin [France] ; Laurent Chouchana [France] ; Fanny Rocher [France] ; Milou-Daniel Drici [France]"Off-label" use of hydroxychloroquine, azithromycin, lopinavir-ritonavir and chloroquine in COVID-19: A survey of cardiac adverse drug reactions by the French Network of Pharmacovigilance Centers.
000149 (2020) S. Defoort-Dhellemmes [France][Is there a need for ophthalmological surveillance in the case of short-term hydroxychloroquine treatment during this COVID-19 pandemic?]
000A31 (2020) Franck Touret [France] ; Xavier De Lamballerie [France]Of chloroquine and COVID-19.
000C03 (2020) Matthias Jacquet-Lagrèze [France] ; Zakaria Riad [France] ; Elisabeth Hugon-Vallet [France] ; Arnaud Ferraris [France] ; Jean-Luc Fellahi [France]Left ventricular dysfunction in COVID-19: A diagnostic issue.
000D92 (2020) Ibrahim Yakoub-Agha [France]Hydroxychloroquine in Covid-19: Does the end justify the means?
001278 (2020) James A. Watson [Thaïlande, Royaume-Uni] ; Joel Tarning [Thaïlande, Royaume-Uni] ; Richard M. Hoglund [Thaïlande, Royaume-Uni] ; Frederic J. Baud [France] ; Bruno Megarbane [France] ; Jean-Luc Clemessy [France] ; Nicholas J. White [Thaïlande, Royaume-Uni]Concentration-dependent mortality of chloroquine in overdose.
001579 (2020) Hervé Javelot [France] ; Wissam El-Hage [France] ; Guillaume Meyer [France] ; Guillaume Becker [France] ; Bruno Michel [France] ; Coraline Hingray [France]COVID-19 and (hydroxy)chloroquine-azithromycin combination: Should we take the risk for our patients?
001695 (2020) Paul Gougis [France] ; Charlotte Fenioux [France] ; Christian Funck-Brentano [France] ; Marianne Veyri [France] ; Joseph Gligorov [France] ; Caroline Solas [France] ; Jean-Philippe Spano [France]Anticancer drugs and COVID-19 antiviral treatments in patients with cancer: What can we safely use?
001766 (2020) Jérémie Delaleu [France] ; Benjamin Deniau [France] ; Maxime Battistella [France] ; Adèle De Masson [France] ; Benoit Bensaid [France] ; Marie Jachiet [France] ; Ingrid Lazaridou [France] ; Martine Bagot [France] ; Jean-David Bouaziz [France]Acute generalized exanthematous pustulosis induced by hydroxychloroquine prescribed for COVID-19.
001771 (2020) Olivier Voisin [France] ; Erwan Le Lorc'H [France] ; Annabelle Mahé [France] ; Philippe Azria [France] ; Marie-Françoise Borie [France] ; Sidonie Hubert [France] ; Elodie Ménage [France] ; Jean-Christophe Guillerm [France] ; Jean-Jacques Mourad [France]Acute QT Interval Modifications During Hydroxychloroquine-Azithromycin Treatment in the Context of COVID-19 Infection.
001810 (2020) Tamim Alsuliman [France] ; Lugien Alasadi [Oman] ; Banan Alkharat [Oman] ; Micha Srour [France] ; Ali Alrstom [Syrie]A review of potential treatments to date in COVID-19 patients according to the stage of the disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Hydroxychloroquine (adverse effects)" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i  \
                -Sk "Hydroxychloroquine (adverse effects)" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    KwdEn.i
   |clé=    Hydroxychloroquine (adverse effects)
}}
Wicri

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021